prescript growth
updat forecast estim may
busi strategi outlook
found walgreen boot allianc lead
pharmaci retail leverag scale provid conveni
current compani gener nearli billion revenu
dispens billion prescript annual repres
quarter drug market domest store
strateg locat high traffic area gener
million per store drive scale help enabl compani
negoti effect supplier scale remain critic
increasingli competit market wit
ration subscal peer core busi center
around pharmaci account nearli three fourth
revenu main driver traffic manag need
pull volum recent acquir rite aid
locat along store abroad reimburs stabil
manag focus leverag scale foster
strateg partnership increas traffic cross sell
opportun long term focu improv coordin care
histor compani strategi base footprint
expans establish scalabl infrastructur
focu evolv concentr shift improv
store util strateg align healthcar partner
address macro trend local commun healthcar
incur oper capit invest
success complet numer clinic cpg trial
success roll initi incorpor
guidanc serv off-set continu
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research may
estim may
price data may
rate updat may
currenc amount express
busi strategi outlook
methodolog valu compani
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
oper locat state
countri core defens posit primarili around
pharmaci place high traffic locat current compani
largest retail pharmaci market share around exclud mail
provid signific cost advantag scale annual
compani gener billion revenu consist retail
pharmaci around pharmaci around
pharmaceut wholesal around establish strateg
partnership offer increment servic increas averag revenu per
custom equiti stake
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
walgreen boot allianc prescript
cost advantag neg trend rate lower
fair valu estim per share believ
walgreen abl leverag scale foster
benefici partnership better util store abat
commod price pressur off-set neg
walgreen lead pharmaci retail signific
scale gener nearli billion revenu
dispens billion prescript annual -- quarter
market expans infrastructur strateg
locat store front high traffic area gener
million sale per store notabl better closest
peer million doubl pharmaci
averag million scale remain critic
increasingli competit market wit
ration subscal peer core busi
center around pharmaci account nearli three
fourth revenu main driver traffic
balanc domest busi consist front end retail
almost equal split health beauti well
addit commod product
wholesal repres busi
round revenu manag need pull
increment volum acquir locat
intern store
manag focus leverag scale foster
strateg partnership increas traffic cross sell
opportun long-term focu improv co-
ordin care concentr improv store
util address macro trend local commun
healthcar walgreen incur oper
capit invest success complet variou
strateg partnership trial success roll
initi incorpor guidanc
off-set reimburs deterior
lower fair valu estim per
share reflect current reimburs
environ impact cost save initi
public privat third parti payor increas shift
mix toward day prescript medicar part
continu growth specialti drug like weigh
overal profit initi like improv
effici fiscal strateg initi
includ forecast like materi
fiscal
multipl free cash flow yield dividend
forecast base core assumpt legaci
front end revenu legaci busi rite
aid store sinc figur discret provid
triangul report figur morningstar
estim arriv volum price driver
assumpt includ split specialti legaci
pharmaceut base indic fiscal
specialti revenu north billion
estim legaci pharmaci busi grown
inflationari rate rite aid contribut includ
third quarter base earn call
howev may variabl base time
transact close quarterli result aris
differ fiscal year end base case assum
specialti drug grow mid doubl digit annual
discret period larg driven volum also
expect manag pull increment pharmaci
front end revenu net store
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
strateg initi off-set reimburs
pressur addit manag need pull
increment volum acquir store
make progress cost save initi
bull-cas fair valu estim per share
scenario abl grow domest retail pharmaci
high end industri spend project nearli
also grow wholesal inflationari rate
scenario oper margin anticip improv
rel base case basi point
roughli basi point annual discret forecast
base assumpt reimburs
materi impact near term off-set
implement cost save initi leverag
increment revenu gener strateg initi
bear-cas fair estim per share
scenario revenu declin fiscal grow
inflationari rate discret forecast due
continu deterior domest intern
reimburs result oper profit estim
basi point base case
walgreen boot allianc assign narrow moat
rate cost advantag
establish signific scale enabl
foster meaning partnership negoti
power supplier differenti abil
gener signific volum conveni locat
across nation firm dispens billion adjust
prescript annual account nearli three quarter
overal sale
approxim million revenu
foot notabl better sale per store closest
peer million doubl pharmaci
averag million abil drive increment
account close locat clip slightli
inflationari rate although anticip front end
sale
fiscal
conserv estim slight drag overal
sale manag abl strike partnership
competit cpg price manufactur
intern busi anticip stabil
materi contribut european reimburs
foreign exchang pressur abat wholesal anticip
grow inflationari rate larg driven continu
migrat legaci walgreen rite aid volum
uncertainti rate stand medium due
increas competit environ execut risk
strateg initi addit potenti regulatori
chang associ increas price transpar
part valuat framework addit
base-cas dcf also model bull bear case
valuat scenario critic debat
surround compani abil better util store
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
volum averag store like driven
conveni orient concept help best
locat regularli updat store coupl macro
trend includ prefer age popul
purchas prescript physic
locat
de-emphasize mail order pharmaci scale allow
compani leverag fix cost pharmacist rent
effect sub-scal peer contribut
declin market share smaller
pharmaci deterior third largest competitor
strateg partnership conscious
share price inform improv transpar drive
traffic negoti payor
opportun key partnership serv differ purpos
includ distribut
healthcar payor optum pbm
specif exampl favor distribut term
contract contract extend
includ day payment doubl
market norm day day closest peer
enabl compani optim work capit
account third abc revenu
charg averag fee basi point versu basi
point closest peer note drug channel
compar report ebit margin
includ increas inventori threshold direct deliveri
retail locat shift inventori
distributor reduc need maintain central
distribut center significantli lower overhead
expens arrang also supplement
synergi wbad swiss gener purchas joint
ventur
custom combin wbad
prime recent acquisit rite aid store manag
roughli third gener drug volum help
price negoti sourc stake
convers warrant equiti
scale also provid abil establish strateg
partnership enhanc store traffic one partnership
prime llc form alliancerx
third-largest specialti provid arrang
compliment focu limit distribut drug ldd
specialti drug key driver overal drug spend
signific compon fda drug approv
partnership sizabl specialti contract
cross shield feder employe program away
incumb contract estim billion
result estim gener annual
specialti revenu billion repres nearli
third specialti market
compani also conduct partnership trial
cost reflect oper result none
benefit includ futur period
key partnership includ lab corp
strong price leverag cpg item abil
obtain price could improv cross sell
front end product result improv profit
trial recent complet kentucki market
grocer lead market share manag roll
similar store store concept other
ancillari servic lab imag primari care clinic
variou clinic servic audiolog optic
improv util stock space longer
need direct store deliveri
initi like foster increas foot traffic
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
retail declin partial self-inflict
manag conscious ration unprofit
front-end sku last quarter longer caus
neg drag profit beauti well
account approxim front end sale
continu partial off-set declin cpg retail sale
longer term object would increas penetr
brand product boot increas
gross margin front end sale similar level current
achiev europ nearli doubl gross
margin
addit benefit declin
pharmaci market share mass merchant grocer
smaller nation chain grown
market share last sever year support
posit scale critic maintain competit
posit retail pharmaci
object recent announc partnership
advoc healthcar offer primari care
lastli consid one valu tenant
landlord reit compani signific
negoti leverag especi import
leas locat mani year term
leas need renew near term view
negoti rate like benefit base
sensit market rate fulli load retail rental rate
feet estim dollar negoti
favor would benefit compani million
annual believ figur
incorpor guidanc may possibl come
play long term cost save initi
compani scale instrument steadili
grow quarterli market share novemb
februari support doubl digit return
believ underli moat sourc attribut
weaken time due increas reimburs
pressur public privat third parti payor
increas on-line competit despit implement
intern strateg initi overal return like
short histor norm prior dip
cost capit fiscal
integr allianc boot acquisit
lawsuit around fail therano partnership sinc
legal settlement senior execut
replac expect minor continu margin
expans issu continu fade
cpg compon roughli half front end retail sale
roughli overal sale declin
consecut quarter increas price competit
commod product mass merchant on-line
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
largest retail pharmaci vast network
abl reach consum
provid scale cost advantag
ostrateg partnership focus increas store
util clinic partner local commun
healthcar natur extens provid
coordin care increas sticki
oth kroger initi improv cpg price
critic step enabl increas
perform front end oper
oth confluenc reimburs price pressur
increas shift mix toward day prescript
medicar part specialti drug declin
cpg neg impact profit
ohealthcar reform recent controversi price
transpar like increas stock volatil
could pose fundament threat
oth firm face increas price competit
mass merchant internet retail consum
commod product neg impact
front end growth profit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
fiscal compani nearli billion cash
equival off-set billion debt
debt/capit ratio fiscal gross leverag
portion cash balanc use acquisit
approxim store appear
firm need issu new debt believ
firm abl rebuild cash balanc
normal cours busi free cash flow gener
billion fiscal transact
expect level return normal level billion
annual common stock dividend averag
billion last coupl year forward yield
repurchas billion worth
stock last coupl year manag
indic plan repurchas million worth
balanc fiscal year longer term manag
expect purchas roughli billion annual
oper matur competit market signific
share main risk associ reimburs
pressur public privat third parti payor
increas shift mix toward day prescript
medicar part increas cost procur
pharmaceut signific chang feder
state drug regul compani signific
market share entri new competitor would like
unlik signific chang economi
market dynam could pose risk decreas
util drug either driven slower new drug
fewer altern gener option
formulari constraint
manag abil leverag signific fix cost
maintain store high rent staf
pharmacist may also
impact
pbm would
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
consolid healthcar compani provid
could influenc prescript fill
intern oper face risk
associ reimburs mix cost procur
competit posit entri new competitor
decreas util risk would vari
base countri compani oper
oper intern countri lastli signific
currenc could neg
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
stewardship rate overal leader season
divers consum background see
stefano pessina firm largest sharehold
ceo execut vice chairman sinc januari
posit undoubtedli given iron grip
firm perspect everi aspect
oper strategi driven pessina larg
view mani current sharehold compet
retail given earlier turnaround allianc boot
busi believ extens success
histori oper europ largest retail pharmaci
believ new manag team led stefano
foster strateg partnership add posit
walgreen
partnership lab corp prime
compani scale mani effici also
roll acquisit rite aid store
significantli lower throughput product
ceo/director/vic chairman
repres date owner name posit common share held report holder issuer
capit research manag compani
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
walgreen boot allianc prescript
cost advantag neg trend rate lower
fair valu estim per share believ
walgreen abl leverag scale foster
benefici partnership better util store abat
commod price pressur off-set neg
walgreen lead pharmaci retail signific
scale gener nearli billion revenu
dispens billion prescript annual -- quarter
market expans infrastructur strateg
locat store front high traffic area gener
million sale per store notabl better closest
peer million doubl pharmaci
averag million scale remain critic
increasingli competit market wit
ration subscal peer core busi
center around pharmaci account nearli three
fourth revenu main driver traffic
balanc domest busi consist front end retail
almost equal split health beauti well
addit commod product
wholesal repres busi
round revenu manag need pull
increment volum acquir locat
intern store
manag focus leverag scale foster
strateg partnership increas traffic cross sell
opportun long-term focu improv co-
ordin care concentr improv store
util address macro trend local commun
healthcar walgreen incur oper
capit invest success complet variou
strateg partnership trial success roll
initi incorpor guidanc
off-set reimburs deterior
light
walgreen miss neg reimburs
trend soft retail volum guidanc lower
result fell short expect revenu
ep
reimburs soft retail volum market
condit factor exacerb lap
especi strong flu season prior year light
year-to-d perform manag
guidanc year believ poor perform
support no-moat rate firm
maintain fair valu estim
second quarter revenu grew year year
constant currenc basi billion
organ sale exclud acquisit rite aid store grew
 retail pharmaci sale increas
organ basi despit increas
market share increas overal
store sale prescript pharmaci grew
respect retail sale increas overal
declin organ basi overal increas
pharmaci volum off-set lower gross
margin oper incom normal ep declin
respect manag continu
repurchas share drive averag share count
midpoint ep guidanc fiscal
roughli consensu estim prior
guidanc growth manag anticip mid-
high-single-digit growth
fiscal
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
implement
off-set
reimburs pressur increas volum longer
term manag invest roughli billion three
year transform store destin improv
digit product offer
digit cost manag initi
store optim anticip contribut billion
annual save
headwind collabor dec
walgreen boot allianc report result first
quarter fiscal novemb
consist expect expect
signific chang valuat overal firm top
line increas heavili driven store
acquisit march growth exclud
closer constant currenc bottom
line gross margin pressur counter strong
benefit tax reform adjust tax rate fell
allow adjust net earn
growth share repurchas drove adjust ep growth
even higher given tailwind tax reform
quarter annual start calendar
continu tailwind billion expect share
repurchas fiscal year think adjust
ep growth guidanc constant currenc full fiscal
year reason new cost-cut program
save billion annual expect three
year also help counter persist headwind
firm face see share fairli valu
continu see competit landscap pharmaci
busi consolid competitor drug price
weak uncertainti surround retail growth
contribut lack econom moat
verili healthcar subsidiari alphabet
focus use technolog reduc cost improv
care patient chronic condit walgreen
start small pilot project improv medic
adher partnership sanofi diabet
manag walgreen employe potenti
benefit walgreen bottom line like
appar near term build walgreen prior
collabor firm includ
aim increas conveni
dive quarter result top-lin strength
pharmaci busi counter continu weak
retail intern pharmaci pharmaci
gross margin continu see reimburs contract
pressur pharmaci busi sale growth
translat organ growth exclud
rite-aid acquisit gross margin divis
basi point due specialti shift dilut
januari
compar pharmaci growth
prescript share retail sale
compar basi de-emphasi tobacco
strong first quarter fiscal attribut
hurrican strong cold/flu season even
adjust currenc headwind account chang
divestitur sale walgreen
pharmaci segment declin organ
 walgreen cite strong rel perform
overal weaken retail pharmaci market
expect trend revers near term
walgreen saw hit adjust oper
margin quarter adjust oper incom
pressur largest retail pharmaci segment
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
basi point also intern retail
pharmaci basi point distribut
basi point larg due currenc impact
emerg market growth remain strong despit
continu cost-cut improv sg
percentag sale exist retail pharmaci
segment sg pressur retail pharmaci
larg due
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end august
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
